Sofindev

Managing Partners Eric Van Droogenbroeck and Jan Camerlynck lead the firm, supported by Partners Carlo Daelemans, Jean-Roger de Bandt, Lodewijk Koeman, and Christophe Steverlynck. The investment committee is drawn from this partnership group. Responsibility for origination and execution is distributed across Investment Directors Nicolas De Bruyne, Sven Vandewiele, Louise Bouckaert and the broader team.

Sofindev maintains distinct investment vehicles for each country rather than a single Benelux fund. The firm operates from its headquarters in Diegem and a dedicated Amsterdam office, which allows each fund to align deployment with the local M&A cycle. This structure has been a feature of the firm for most of its 35-year history.

Sofindev invests directly in operating companies, taking majority or significant minority positions in mid-sized Benelux businesses. The firm does not publicize a fund-of-funds program or LP commitments to external general partners. Its focus is on buyout, growth-equity, and management-succession transactions where it can take a board seat.

The firm targets buyouts, growth capital rounds, and management buy-in or succession situations. It does not invest at the seed or early-stage venture level. Portfolio companies are typically established small and medium-sized enterprises with existing revenue, management teams, and a path to international expansion.

Sofindev has not published a formal exclusion list. Its current portfolio concentrates on business services, health and safety, industrial technology, software, and logistics. The firm has no disclosed holdings in biotechnology, pharmaceutical development, or consumer internet, suggesting a preference for companies with physical operations or enterprise B2B models.

Sofindev has not disclosed the origin of its founding capital or named a single wealth-owning family as its anchor investor. The firm operates as an independent private equity manager, raising funds from institutional investors and family offices in the Benelux region and beyond, but the composition of its LP base remains private.

There is no publicly disclosed philanthropic foundation, donor-advised fund, or impact-investment vehicle affiliated with Sofindev or its managing partners. The firm embeds sustainability considerations into its investment process but does not separate them into a dedicated charitable entity.